367
Participants
Start Date
December 14, 2023
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2030
Cretostimogene Grenadenorepvec
Engineered Oncolytic Adenovirus
n-dodecyl-B-D-maltoside
Transduction-enhancing agent
Integrated Medical Professionals PLLC, New York
NYU Langone Health, New York
Icahn School of Medicine at Mount Sinai, New York
Montefiore Medical Center, The Bronx
Stony Brook University, Stony Brook
Associated Medical Professionals of NY, Syracuse
SUNY Upstate Medical University, Syracuse
University of Rochester Medical Center, Rochester
Penn State Health Milton S. Hershey Medical Center, Hershey
Keystone Urology Specialists, Lancaster
Midlantic Urology, Bala-Cynwyd
University of Pennsylvania - Perelman School of Medicine, Philadelphia
Thomas Jefferson University, Philadelphia
MedStar Washington Hospital Center, Washington D.C.
Chesapeake Urology Associates, LLC, Baltimore
Johns Hopkins Hospital Green Spring Station, Baltimore
Urology of Virginia (UVA) - Virginia Beach (Devine-Tidewater Urology), Virginia Beach
Charleston Area Medical Center, Charleston
Duke Cancer Center, Durham
Lowcountry Urology Clinics, North Charleston
Medical University of South Carolina, Charleston
Carolina Urologic Research Center, Myrtle Beach
Emory Winship Cancer Center, Atlanta
Velocity Clinical Research- Savanah Urological Associates, Savannah
Advanced Urology Institute, Daytona Beach
Mayo Clinic Cancer Center, Jacksonville
University of Miami, Miami
Advanced Urology Institute, LLC, Largo
Lakeland Regional Health, Lakeland
Urology Centers of Alabama PC, Homewood
Urology Associates, P.C., Nashville
Vanderbilt University Medical Center, Nashville
The Conrad Pearson Clinic, Germantown
The Urology Group, Southaven
Ohio State University Comprehensive Cancer Center, Columbus
University of Toledo, Toledo
Urology Group, Cincinnati
Urology of Indiana, LLC, Carmel
Urology of Indiana, Greenwood
First Urology, PSC, Louisville
Comprehensive Urology, Roseville
Michigan Institute of Urology, PC, Troy
Henry Ford Hospital, Detroit
Urology Center of Iowa Research, West Des Moines
University of Wisconsin Medical Foundation, Madison
Mayo Clinic, Rochester
UroPartners LLC, Glenview
Rush University Medical Center, Chicago
University of Chicago, Chicago
Objective Health - Specialty Clinical Research of St. Louis, St Louis
The University of Kansas Cancer Center, Westwood
Wichita Urology Group, Wichita
Southern Urology, Lafayette
Regional Urology, LLC, Shreveport
Arkansas Urology PA, Little Rock
University of Texas Southwestern Medical Center, Dallas
Urology Associates of North Texas, Arlington
Houston Methodist Research Institute, Houston
MD Anderson Cancer Center, Houston
Michael E. DeBakey VA Medical Center, Houston
Houston Metro Urology, Houston
Urology San Antonio PA, San Antonio
UT Health San Antonio, San Antonio
Urology Austin, PLLC, Austin
Amarillo Urology Research, LLC, Amarillo
Colorado Clinical Research, Aurora
Urology Associates, PC, Lone Tree
University of Utah- Huntsman Cancer Institute, Salt Lake City
Banner MD Anderson Cancer Center, Gilbert
Mayo Clinic, Scottsdale
Arizona Institute of Urology PLLC, Tucson
Urology Nevada, Reno
USC/Keck Department of Urology, Los Angeles
Tower Urology, Los Angeles
Sun Kim Urology, Orange
University of California Irvine Medical Center (UCIMC), Orange
Stanford University School of Medicine, Stanford
University of California Davis Cancer Center, Sacramento
Oregon Urology Insititute, Springfield
Benaroya Research Institute at Virginia Mason, Seattle
University of Washington Medical Center, Seattle
Spokane Urology- Southside, Spokane
Duly Health and Care, Lisle
Michael G. Oefelein MD Clinical Trials, Bakersfield
Hartford HealthCare Medical Group, Hartford
Brigham and Women's Hospital, Boston
Cancer Center at Beth Israel Deaconess Medical Center - Research, Boston
Garden State Urology, LLC- Morristown Medical Center, Morristown
Rutgers Cancer Institute of New Jersey - Cancer Center, New Brunswick
The Miriam Hospital, Providence
Vancouver Prostate Centre, Vancouver
Nova Scotia Health Centre of Applied Urology Research, Halifax
London Health Sciences Centre, London
University Health Network (UHN) - Princess Margaret Cancer Centre, Toronto
McGill University Health Center - Montreal General Hospital, Montreal
Lead Sponsor
CG Oncology, Inc.
INDUSTRY